Kenji Imai

5.2k total citations
157 papers, 4.0k citations indexed

About

Kenji Imai is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Kenji Imai has authored 157 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 48 papers in Hepatology and 46 papers in Epidemiology. Recurrent topics in Kenji Imai's work include Liver Disease Diagnosis and Treatment (42 papers), Liver Disease and Transplantation (30 papers) and Nutrition and Health in Aging (23 papers). Kenji Imai is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Liver Disease and Transplantation (30 papers) and Nutrition and Health in Aging (23 papers). Kenji Imai collaborates with scholars based in Japan, Germany and United States. Kenji Imai's co-authors include Masahito Shimizu, Koji Takai, Tatsunori Hanai, Makoto Shiraki, Atsushi Suetsugu, Hisataka Moriwaki, Rudi Balling, Bettina Wilm, Haruhiko Koseki and Kayoko Nishimura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Kenji Imai

152 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Imai Japan 35 1.6k 974 898 779 571 157 4.0k
Osamu Hashimoto Japan 32 1.9k 1.1× 537 0.6× 893 1.0× 577 0.7× 303 0.5× 169 4.1k
Jelena Mann United Kingdom 36 2.0k 1.3× 1.1k 1.1× 1.5k 1.7× 979 1.3× 354 0.6× 65 5.0k
Caroline Wilson United Kingdom 25 1.4k 0.8× 893 0.9× 811 0.9× 376 0.5× 251 0.4× 55 3.9k
Rebekah Karns United States 27 1.1k 0.7× 683 0.7× 671 0.7× 336 0.4× 245 0.4× 75 3.0k
Deborah Stroka Switzerland 38 2.2k 1.3× 472 0.5× 734 0.8× 556 0.7× 493 0.9× 105 4.7k
Kouichi Miura Japan 25 1.3k 0.8× 425 0.4× 2.2k 2.4× 1.3k 1.6× 213 0.4× 78 3.7k
Hyon‐Seung Yi South Korea 31 1.2k 0.7× 646 0.7× 867 1.0× 348 0.4× 210 0.4× 99 3.0k
Hyun Sub Cheong South Korea 30 1.0k 0.6× 583 0.6× 419 0.5× 187 0.2× 639 1.1× 163 2.9k
Thomas G. Bird United Kingdom 24 1.2k 0.7× 762 0.8× 910 1.0× 1.3k 1.6× 191 0.3× 77 3.7k
Izumi Hayashi Japan 40 1.9k 1.1× 500 0.5× 268 0.3× 297 0.4× 591 1.0× 152 5.0k

Countries citing papers authored by Kenji Imai

Since Specialization
Citations

This map shows the geographic impact of Kenji Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Imai more than expected).

Fields of papers citing papers by Kenji Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Imai. The network helps show where Kenji Imai may publish in the future.

Co-authorship network of co-authors of Kenji Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Imai. A scholar is included among the top collaborators of Kenji Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Imai. Kenji Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Imai, Kenji, Koji Takai, Takao Miwa, et al.. (2025). Psoas Muscle Index as an Independent Predictor of Survival in Patients with Hepatocellular Carcinoma Receiving Systemic Targeted Therapy. Cancers. 17(2). 209–209. 1 indexed citations
3.
Miwa, Takao, Tatsunori Hanai, Kenji Imai, et al.. (2024). Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance. Journal of Gastroenterology. 59(9). 849–857. 7 indexed citations
4.
Imai, Kenji, Takao Miwa, Tatsunori Hanai, et al.. (2024). Unresectable Combined Hepatocellular-cholangiocarcinoma Treated with Combination Therapy Consisting of Durvalumab Plus Tremelimumab. Internal Medicine. 63(19). 2631–2636. 1 indexed citations
5.
Imai, Kenji, Koji Takai, Takao Miwa, et al.. (2024). Lenvatinib Exacerbates the Decrease in Skeletal Muscle Mass in Patients with Hepatocellular Carcinoma, Whereas Atezolizumab Plus Bevacizumab Does Not. Cancers. 16(2). 442–442. 2 indexed citations
6.
Miwa, Takao, Tatsunori Hanai, Kayoko Nishimura, et al.. (2024). Dysphagia risk evaluated by the Eating Assessment Tool-10 is associated with health-related quality of life in patients with chronic liver disease. Nutrition. 124. 112440–112440. 1 indexed citations
7.
Imai, Kenji, Koji Takai, Takao Miwa, et al.. (2024). Adverse Events in Targeted Therapy for Unresectable Hepatocellular Carcinoma Predict Clinical Outcomes. Cancers. 16(18). 3150–3150.
8.
Miwa, Takao, Tatsunori Hanai, Kayoko Nishimura, et al.. (2024). Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study. Clinical Nutrition ESPEN. 63. 267–273. 2 indexed citations
9.
Hanai, Tatsunori, Kayoko Nishimura, Takao Miwa, et al.. (2023). Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis. JGH Open. 7(3). 208–214. 3 indexed citations
10.
Miwa, Takao, Tatsunori Hanai, Kenji Imai, et al.. (2023). A case of A20 haploinsufficiency complicated by autoimmune hepatitis. Hepatology Research. 54(6). 606–611. 2 indexed citations
11.
Hanai, Tatsunori, Takao Miwa, Kenji Imai, et al.. (2023). Effect of Selenium Deficiency on the Development of Overt Hepatic Encephalopathy in Patients with Chronic Liver Disease. Journal of Clinical Medicine. 12(8). 2869–2869. 2 indexed citations
12.
Miwa, Takao, Tatsunori Hanai, Kayoko Nishimura, et al.. (2022). Usefulness of the Global Leadership Initiative on Malnutrition criteria to predict sarcopenia and mortality in patients with chronic liver disease. Hepatology Research. 52(11). 928–936. 32 indexed citations
13.
Hanai, Tatsunori, Kayoko Nishimura, Takao Miwa, et al.. (2022). Usefulness of the Trabecular Bone Score in Assessing the Risk of Vertebral Fractures in Patients with Cirrhosis. Journal of Clinical Medicine. 11(6). 1562–1562. 4 indexed citations
14.
Miwa, Takao, Tatsunori Hanai, Kayoko Nishimura, et al.. (2022). A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis. PLoS ONE. 17(11). e0277829–e0277829. 8 indexed citations
15.
16.
Miwa, Takao, Tatsunori Hanai, Kayoko Nishimura, et al.. (2021). Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis. Journal of Parenteral and Enteral Nutrition. 46(4). 858–866. 22 indexed citations
17.
Miwa, Takao, Yuichiro Hatano, Takahiro Kochi, et al.. (2020). Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review. Clinical Journal of Gastroenterology. 13(5). 882–890. 6 indexed citations
18.
Imai, Kenji, Koji Takai, Takao Miwa, et al.. (2019). Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers. 11(8). 1206–1206. 38 indexed citations
19.
Morioka, Seiji, et al.. (2006). A Food-Borne Norovirus Outbreak at a Primary School in Wakayama Prefecture. Japanese Journal of Infectious Diseases. 59(3). 205–207. 13 indexed citations
20.
Uchiyama, Kazuhiko, Hiroaki Saito, Takeshi Tokuhisa, Kenji Imai, & Masaru Taniguchi. (1987). High Frequency of Loss of Human Kappa Light Chain Expression in Mouse-Human Heterohybridomas. Hybridoma. 6(6). 645–654. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Osamu Hashimoto Breakdown of academic impact, for papers by Jelena Mann Breakdown of academic impact, for papers by Caroline Wilson Breakdown of academic impact, for papers by Rebekah Karns Breakdown of academic impact, for papers by Deborah Stroka Breakdown of academic impact, for papers by Kouichi Miura Breakdown of academic impact, for papers by Hyon‐Seung Yi Breakdown of academic impact, for papers by Hyun Sub Cheong Breakdown of academic impact, for papers by Thomas G. Bird Breakdown of academic impact, for papers by Izumi Hayashi
Rankless by CCL
2026